Symptom prevalence, characteristics and distress in a cancer population
- PMID: 7920492
- DOI: 10.1007/BF00435383
Symptom prevalence, characteristics and distress in a cancer population
Abstract
Despite the importance of symptom control in the cancer population, few studies have systematically assessed the prevalence and characteristics of symptoms or the interactions between various symptom characteristics and other factors related to quality of life (QOL). As part of a validation study of a new symptom assessment instrument, inpatients and outpatients with prostate, colon, breast or ovarian cancer were evaluated using the Memorial Symptom Assessment Scale and other measures of psychological condition, performance status, symptom distress and overall quality of life. The mean age of the 243 evaluable patients was 55.5 years (range 23-86 years); over 60% were women and almost two-thirds had metastatic disease. The Karnofsky Performance Status (KPS) score was < or = 80 in 49.8% and 123 were inpatients at the time of assessment. Across tumour types, 40-80% experienced lack of energy, pain, feeling drowsy, dry mouth, insomnia, or symptoms indicative of psychological distress. Although symptom characteristics were variable, the proportion of patients who described a symptom as relatively intense or frequent always exceeded the proportion who reported it as highly distressing. The mean (+/- SD range) number of symptoms per patient was 11.5 +/- 6.0 (0-25); inpatients had more symptoms than outpatients (13.5 +/- 5.4 vs. 9.7 +/- 6.0, p < 0.002) and those with KPS < or = 80 had more symptoms than those with KPS > 80 (14.8 +/- 5.5 vs. 9.2 +/- 4.9, p < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.Eur J Cancer. 1994;30A(9):1326-36. doi: 10.1016/0959-8049(94)90182-1. Eur J Cancer. 1994. PMID: 7999421
-
Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment.Cancer. 2000 Mar 1;88(5):1175-83. doi: 10.1002/(sici)1097-0142(20000301)88:53.0.co;2-n. Cancer. 2000. PMID: 10699909
-
The measurement of symptoms in children with cancer.J Pain Symptom Manage. 2000 May;19(5):363-77. doi: 10.1016/s0885-3924(00)00127-5. J Pain Symptom Manage. 2000. PMID: 10869877
-
Assessment of symptom clusters in people with cancer.J Natl Cancer Inst Monogr. 2004;(32):98-102. doi: 10.1093/jncimonographs/lgh009. J Natl Cancer Inst Monogr. 2004. PMID: 15263048 Review.
-
Symptom assessment.Hematol Oncol Clin North Am. 1996 Feb;10(1):21-39. doi: 10.1016/s0889-8588(05)70325-7. Hematol Oncol Clin North Am. 1996. PMID: 8821558 Review.
Cited by
-
Determination of cutpoints for low and high number of symptoms in patients with advanced cancer.J Palliat Med. 2012 Sep;15(9):1027-36. doi: 10.1089/jpm.2012.0045. Epub 2012 Aug 1. J Palliat Med. 2012. PMID: 22853731 Free PMC article. Clinical Trial.
-
Symptom assessment in cancer patients.Curr Oncol Rep. 2002 May;4(3):256-63. doi: 10.1007/s11912-002-0024-0. Curr Oncol Rep. 2002. PMID: 11937017 Review.
-
Symptom clusters in patients with advanced cancers.Support Care Cancer. 2009 Sep;17(9):1223-30. doi: 10.1007/s00520-009-0577-7. Epub 2009 Jan 30. Support Care Cancer. 2009. PMID: 19184126
-
Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy.Support Care Cancer. 2017 Jun;25(6):1931-1939. doi: 10.1007/s00520-017-3593-z. Epub 2017 Feb 3. Support Care Cancer. 2017. PMID: 28160076 Free PMC article.
-
The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer.Cancer. 2017 Dec 1;123(23):4720-4727. doi: 10.1002/cncr.30912. Epub 2017 Oct 23. Cancer. 2017. PMID: 29057450 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials